Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.
Stevens
K E
KE
Department of Pharmacology, University of Colorado Health Sciences Center, Denver.
Meltzer
J
J
Rose
G M
GM
D000161:Acoustic Stimulation; D000818:Animals; D001307:Auditory Perception / Q000502:physiology; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D006185:Habituation, Psychophysiologic / Q000502:physiology*; D009638:Norepinephrine / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011941:Receptors, Adrenergic / Q000187:drug effects; D012559:Schizophrenia / Q000503:physiopathology; D012565:Schizophrenic Psychology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D015016:Yohimbine / Q000008:administration & dosage / Q000494:pharmacology*
D011941:Receptors, Adrenergic; D015016:Yohimbine; D009638:Norepinephrine